192 related articles for article (PubMed ID: 31448234)
1. Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland Metastases.
Scouarnec C; Pasquier D; Luu J; le Tinier F; Lebellec L; Rault E; Lartigau E; Mirabel X
Front Oncol; 2019; 9():732. PubMed ID: 31448234
[No Abstract] [Full Text] [Related]
2. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases.
Voglhuber T; Kessel KA; Oechsner M; Vogel MME; Gschwend JE; Combs SE
BMC Cancer; 2020 Jun; 20(1):536. PubMed ID: 32513136
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiation therapy for adrenal gland metastases: Outcomes and toxicity.
Toesca DAS; Koong AJ; von Eyben R; Koong AC; Chang DT
Adv Radiat Oncol; 2018; 3(4):621-629. PubMed ID: 30370363
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiotherapy for treatment of adrenal metastases.
Chawla S; Chen Y; Katz AW; Muhs AG; Philip A; Okunieff P; Milano MT
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):71-5. PubMed ID: 19250766
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiation therapy (SBRT) for patients with oligometastatic/oligoprogressive adrenal metastases: Outcomes and toxicities profile in a monoinstitutional study.
Facondo G; Vullo G; Valeriani M; Ascolese AM; De Sanctis V; Osti MF
Cancer Treat Res Commun; 2021; 29():100481. PubMed ID: 34700142
[TBL] [Abstract][Full Text] [Related]
6. Two-institution results of Stereotactic Body Radiation Therapy (SBRT) for treating adrenal gland metastases from liver cancer.
Xu B; Zhao X; Chen D; Zhao W; Wang X; Ding C; Yuan Z; Zhang H
BMC Cancer; 2023 Jan; 23(1):73. PubMed ID: 36681809
[TBL] [Abstract][Full Text] [Related]
7. Long-term local control achieved after hypofractionated stereotactic body radiotherapy for adrenal gland metastases: a retrospective analysis of 34 patients.
Scorsetti M; Alongi F; Filippi AR; Pentimalli S; Navarria P; Clerici E; Castiglioni S; Tozzi A; Reggiori G; Mancosu P; Ricardi U
Acta Oncol; 2012 May; 51(5):618-23. PubMed ID: 22263925
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiation therapy for adrenal gland metastases: A multi-institutional outcome analysis.
Yuste C; Passerat V; Calais G; Schipman B; Vaugier L; Paumier A; Huertas A; Hemery CG; Debelleix C; Chamois J; Blanchard N; Septans AL; Pointreau Y
Clin Transl Radiat Oncol; 2024 Mar; 45():100708. PubMed ID: 38162282
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiotherapy for the treatment of oligometastatic gynecological malignancy in the abdomen and pelvis: A single-institution experience.
Smile TD; Reddy CA; Qiao-Guan G; Winter WI; Stephans KL; Woody NM; Balagamwala EH; Amarnath SR; Magnelli A; AlHilli MM; Michener CM; Mahdi H; DeBernardo RL; Rose PG; Cherian SS
J Radiosurg SBRT; 2021; 7(3):189-197. PubMed ID: 33898082
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiation therapy (SBRT) of adrenal gland metastases in oligometastatic and oligoprogressive disease.
Reshko LB; Gaskins JT; Silverman CL; Dunlap NE
Rep Pract Oncol Radiother; 2021; 26(3):325-340. PubMed ID: 34277086
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic Body Radiation Therapy for Oligometastatic Ovarian Cancer: A Step Toward a Drug Holiday.
Lazzari R; Ronchi S; Gandini S; Surgo A; Volpe S; Piperno G; Comi S; Pansini F; Fodor C; Orecchia R; Tomao F; Parma G; Colombo N; Jereczek-Fossa BA
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):650-660. PubMed ID: 29893277
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiation therapy for adrenal gland metastases: outcome and predictive factors from a multicenter analysis.
Franzese C; Nicosia L; Facondo G; Lo Faro L; Cuccia F; Vullo G; Osti MF; Alongi F; Scorsetti M
Clin Exp Metastasis; 2021 Dec; 38(6):511-518. PubMed ID: 34651241
[TBL] [Abstract][Full Text] [Related]
13. SBRT to adrenal metastases provides high local control with minimal toxicity.
Plichta K; Camden N; Furqan M; Hejleh TA; Clamon GH; Zhang J; Flynn RT; Bhatia SK; Smith MC; Buatti JM; Allen BG
Adv Radiat Oncol; 2017; 2(4):581-587. PubMed ID: 29204525
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: A Retrospective, Single-Center Study of 55 Patients.
Bhandari RP; Stanford JD; Packianathan S; Duggar WN; Kanakamedala MR; Zhang X; Giri SP; Kumar PP; Harrell LM; Mangana SH; Yang C; Vijayakumar S
Oncology; 2016; 91(4):194-204. PubMed ID: 27427761
[TBL] [Abstract][Full Text] [Related]
15. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic Body Radiotherapy for Inoperable Liver Tumors: Results of a Single Institutional Experience.
Hijazi H; Campeau MP; Roberge D; Donath D; Lapointe R; Vandenbroucke-Menu F; Taussky D; Boudam K; Chan G; Bujold A; Delouya G
Cureus; 2016 Dec; 8(12):e935. PubMed ID: 28123916
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and outcomes of stereotactic body radiotherapy in adrenal gland metastases.
Kekilli E; Demirkasımoğlu T
J Cancer Res Ther; 2023 Apr; 19(Supplement):S47-S51. PubMed ID: 37147982
[TBL] [Abstract][Full Text] [Related]
18. Outcomes and toxicities in oligometastatic patients treated with stereotactic body radiotherapy for adrenal gland metastases: A multi-institutional retrospective study.
Baydoun A; Chen H; Poon I; Badellino S; Dagan R; Erler D; Foote MC; Louie AV; Redmond KJ; Ricardi U; Sahgal A; Biswas T
Clin Transl Radiat Oncol; 2022 Mar; 33():159-164. PubMed ID: 35243027
[TBL] [Abstract][Full Text] [Related]
19. Proton stereotactic body radiation therapy for liver metastases-results of 5-year experience for 81 hepatic lesions.
Coffman AR; Sufficool DC; Kang JI; Hsueh CT; Swenson S; McGee PQ; Nagaraj G; Patyal B; Reeves ME; Slater JD; Yang GY
J Gastrointest Oncol; 2021 Aug; 12(4):1753-1760. PubMed ID: 34532125
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
